ShouTi grabs $100m Series B
ShouTi Inc., a clinical-stage biopharmaceutical company, has secured $100 million in Series B financing.
ShouTi Inc., a clinical-stage biopharmaceutical company, has secured $100 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination
